Immunofluorescence expression of astrocyte and neuronal cells in brain tissues following the injury. by Ghaith A. Bahader (21387572)

“…(B) Analysis of astrocyte cell counts in the peri-lesional areas showed a significant increase in cell numbers in the TBI/H groups, as compared to the Sham + saline group (* p < 0.05, ** p < 0.001). …”

Lipidomic analysis of epidermis using LC-IMS-CID-MS reveals major changes in CKO// epidermis. by Kevin J. Mills (9270966)

Subjects:

Metabolism of lipids and lipid proteins CKO vs K5Cre Reactome by Kevin J. Mills (9270966)

Subjects:

Ceramide biosynthetic process CKO vs K5Cre GO: Biological Processes. by Kevin J. Mills (9270966)

Subjects:

Conditional deletion of C/EBP in epidermis results in downregulation of transcripts and pathways associated with lipid biosynthesis in epidermis. by Kevin J. Mills (9270966)

Subjects:

UHPLC-MS CKO vs K5Cre results. by Kevin J. Mills (9270966)

Subjects:

Uncropped raw western blot images. by Kevin J. Mills (9270966)

Subjects:

LC-IMS-CID-MS CKO vs K5Cre results. by Kevin J. Mills (9270966)

Subjects:

Fatty acids, triacylglycerol and ketone body metabolism CKO vs K5Cre Reactome. by Kevin J. Mills (9270966)

Subjects:

Phospholipid metabolism CKO vs K5Cre Reactome. by Kevin J. Mills (9270966)

Subjects:

Cholesterol biosynthetic process CKO vs K5Cre GO: Biological Processes. by Kevin J. Mills (9270966)

Subjects:

Targeted analysis of cholesterol and cholesterol esters in epidermis reveals changes in specific cholesterol esters in CKO epidermis. by Kevin J. Mills (9270966)

Subjects:

Localization and conditional deletion of C/EBP in SKH1 mouse epidermis. by Kevin J. Mills (9270966)

Subjects:

Adverse event list. by Stefan Halbherr (21353882)

“…No statistically significant improvements were seen in the Montreal Cognitive Assessment (MoCA) (mean decrease −0.73; 95% CI; −2.1, 0.62; <i>p</i> = 0.255), Epworth Sleepiness Scale (mean increase 0.09; 95% CI; −2.6, 2.8; <i>p</i> > 0.999), Beck Depression Inventory (BDI) (mean decrease −1.27; 95% CI; −3.8, 1.3; <i>p</i> = 0.257), and the Starkstein Apathy Scale (mean increase 0.36; 95% CI; −1.6, 2.4; <i>p</i> = 0.822). …”

Patient characteristics. by Stefan Halbherr (21353882)

“…No statistically significant improvements were seen in the Montreal Cognitive Assessment (MoCA) (mean decrease −0.73; 95% CI; −2.1, 0.62; <i>p</i> = 0.255), Epworth Sleepiness Scale (mean increase 0.09; 95% CI; −2.6, 2.8; <i>p</i> > 0.999), Beck Depression Inventory (BDI) (mean decrease −1.27; 95% CI; −3.8, 1.3; <i>p</i> = 0.257), and the Starkstein Apathy Scale (mean increase 0.36; 95% CI; −1.6, 2.4; <i>p</i> = 0.822). …”

Data Sheet 1_Decreased brain-derived neurotrophic factor expression in chronic kidney disease: integrated clinical and experimental evidence.docx by Juan Chen (61123)

“…</p>Conclusion<p>This study integrated meta-analysis, murine model validation, and single-cell transcriptomic profiling to demonstrate a significant reduction of BDNF in CKD. Furthermore, renal BDNF expression decreased locally, predominantly originating from proximal tubule cells, macrophages, and podocytes, possibly epigenetically inhibited by the upregulation of lnc RNA Bdnf-as.…”

Cumulative MARV shedding in bats from the SOSV-MARV and KASV-MARV experimental cohort. by Amy J. Schuh (8520354)

Subjects:

MARV shedding dynamics in bats from the KASV-MARV experimental cohort. by Amy J. Schuh (8520354)

Subjects:

Experimental design. by Amy J. Schuh (8520354)

Subjects:

Pre- and post-study virus-specific IgG responses for bats in the SOSV-MARV and KASV-MARV experimental cohorts. by Amy J. Schuh (8520354)

Subjects: